Idera Pharmaceuticals (IDRA) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Idera Pharmaceuticals (NASDAQ:IDRA) announced its earnings results on Tuesday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.01, American Banking News reports.
Idera Pharmaceuticals (NASDAQ:IDRA) opened at 2.87 on Tuesday. Idera Pharmaceuticals has a one year low of $1.45 and a one year high of $6.87. The stock’s 50-day moving average is $2.74 and its 200-day moving average is $3.67. The company’s market cap is $236.6 million.
Idera Pharmaceuticals, Inc is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (NASDAQ:IDRA) – and ribonucleic acid (RNA) – based drug candidates.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.